SEC Comment Letter 0000000000-23-012335 to MACROGENICS INC (MGNX) (CIK 0001125345) (MGNX)
MACROGENICS INC (MGNX) (CIK 0001125345)
Date: Nov. 10, 2023 · CIK: 0001125345 · Accession: 0000000000-23-012335
AI Filing Summary & Sentiment
File numbers found in text: 333-275343
Letter
United States securities and exchange commission logo November 9, 2023 Scott Koenig, M.D., Ph.D Chief Executive Officer MacroGenics, Inc. 9704 Medical Center Drive Rockville, MD 20850 Re:MacroGenics, Inc. Registration Statement on Form S-3 Filed November 6, 2023 File No. 333-275343 Dear Scott Koenig: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Reid Hooper, Esq.
Show Raw Text
United States securities and exchange commission logo
November 9, 2023
Scott Koenig, M.D., Ph.D
Chief Executive Officer
MacroGenics, Inc.
9704 Medical Center Drive
Rockville, MD 20850
Re:MacroGenics, Inc.
Registration Statement on Form S-3
Filed November 6, 2023
File No. 333-275343
Dear Scott Koenig:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Reid Hooper, Esq.